| Old Articles: <Older 8731-8740 Newer> |
|---|
 |
Chemistry World
December 4, 2013
Phillip Broadwith |
Celgene buys into anticancer antibodies US firms Celgene and OncoMed have tied up a deal to develop and commercialize biological therapies for cancer.   |
Chemistry World
December 3, 2013
Phillip Broadwith |
New wave of hepatitis C drugs hits US shore Johnson & Johnson's hepatitis C drug Olysio (simeprevir) has been approved by the US Food and Drug Administration. |
Chemistry World
December 2, 2013
Lanay Tierney |
US turnaround on Avandia restrictions Restrictions on the controversial diabetes medication Avandia (rosiglitazone) are to be lifted by the US Food and Drug Administration. |
Chemistry World
November 28, 2013 |
Put the chemistry back in medicinal chemistry Today, synthetic skill is valued and appreciated much less in medicinal chemistry than in chemical development, though it is equally important for both. Much of the blame lies with the mismeasurement of productivity. |
Chemistry World
November 27, 2013
Michael Gross |
MEDIC to kick-start personalised medicine revolution A sensor that can continuously monitor the concentration of a drug in the bloodstream is set to help personalized medicine take off. |
Chemistry World
November 27, 2013
Derek Lowe |
Rolling boulders uphill A lot of preclinical projects don't even get off the ground, and many that do still never deliver anything to the development groups. |
Chemistry World
November 26, 2013
Paul Docherty |
Gone to completion Where is the art of total synthesis headed? |
Chemistry World
November 25, 2013
Phillip Broadwith |
Pfizer teams up with GSK in cancer drug trial Pfizer and GlaxoSmithKline have agreed to run a joint clinical trial to test a combination of Pfizer's candidate molecule palbociclib with GSK's approved drug Mekinist (trametinib) for advanced or metastatic melanoma. |
Chemistry World
November 22, 2013
Phillip Broadwith |
DSM to spin out pharma unit Specialty chemicals producer DSM has agreed a deal with private equity firm JLL to spin out its pharmaceuticals division into a new company. |
Chemistry World
November 21, 2013
Phillip Broadwith |
Rapid DNA sequencing cleared for the clinic The approval covers Illumina's MiSeqDx instrument, together with two diagnostic assay kits for cystic fibrosis that run on it, and a kit that allows clinical labs to develop their own diagnostic tests. |
| <Older 8731-8740 Newer> Return to current articles. |
